
Trading floor: Botanix sinks, Alkane up, DigitalX rallies
Botanix Pharmaceuticals tanks after product update Shares in Botanix Pharmaceuticals (ASX: BOT) were down around 38% at the open after the U.S.-based dermatology company announced an update on the launch of Sofdra, its FDA-approved treatment for primary …